Genius Brands International Inc (GNUS): Chardan Capital Reiterates “Buy” Rating...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Genius Brands International Inc (GNUS)

Reply Private New

Keep Last Read

Replies (2) Next 10 Prev Next

patentminer2013

Send PM Follow Ignore

Followers	16
Posts	1295
Boards Moderated	0
Alias Born	11/15/2007

patentminer2013

Re: None

Saturday, 05/27/2017 9:09:25 PM

Saturday, May 27, 2017 9:09:25 PM

Chardan Capital Reiterates “Buy” Rating for Genius Brands International Inc (GNUS)
May 27th, 2017 - By Jessica Moore - 0 comments
Genius Brands International logoGenius Brands International Inc (OTCMKTS:GNUS)‘s stock had its “buy” rating reissued by Chardan Capital in a research note issued to investors on Wednesday, May 17th. They presently have a $8.00 target price on the stock, down from their previous target price of $10.50. Chardan Capital’s price objective indicates a potential upside of 108.33% from the company’s previous close.

Genius Brands International (OTCMKTS:GNUS) opened at 3.84 on Wednesday. Genius Brands International has a 12-month low of $3.25 and a 12-month high of $8.00. The stock has a 50 day moving average of $4.33 and a 200 day moving average of $4.87.

Keep Last Read

Replies (2) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent GNUS News

Form 8-K - Current report • Edgar (US Regulatory) • 06/21/2024 04:20:16 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/20/2024 10:11:01 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/20/2024 10:04:44 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/29/2024 06:49:57 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 12:34:37 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 12:27:14 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/19/2024 09:29:58 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 04/19/2024 09:29:26 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/16/2024 05:00:31 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/16/2024 01:05:11 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/11/2024 09:15:56 PM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/10/2024 08:10:20 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/09/2024 07:35:12 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 04/09/2024 12:05:33 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/09/2024 12:00:57 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/05/2024 09:15:03 PM
Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 04/01/2024 09:02:05 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/23/2024 01:27:15 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/23/2024 01:24:31 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/23/2024 01:23:08 AM
Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 02/13/2024 10:28:41 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2024 08:34:17 PM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/19/2024 09:30:21 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 01/19/2024 05:15:24 AM
Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 01/12/2024 09:50:35 PM

More GNUS News

InvestorsHub NewsWire

FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM

FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM

Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM

VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM

Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM

HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow